R01AD11 - Triamcinolone |
Not porphyrinogenic |
NP |
Mono.Rationale
Insignificant systemic exposure. Several references stating non-porphyrinogenicity of glucocorticoids.
Mono.ChemicalDescription
Glucocorticoide nasal spray with very low bioavailability.
Mono.SimilarDrugs
Mono.References
| # | Citation details | PubMed ID |
|---|---|---|
| 1. | Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
|
9554242 |
| 2. | Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
|
9074793 |
| Porphyria Drug Lists | ||
| 3. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
| Other sources | ||
| 5. | Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
|
|
Mono.Tradenames
Nasacort 
Nasacor · Triamist 
Nasacort 
Nasacort 
Nasacort 
Nasacort 
Nasalone · Triamcinolon 
Nasacort · Nasacort Allergy 
Nasacort · Triamcinolone 
Nasacort 
Nasacort 
Allespray 
Nasacort · Telnase 
Nasacort · Triamcinolone 
Nasacort · Trinas 
Nasacort 
Nasacort 
Nasacort · Triamcinolone 
Triamcinolone 
Nasacort 
Nasacort